Articles

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Children’s Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Sydney, Australia
Children’s Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Sydney, Australia
CSL Limited, Parkville, Australia
Department of Microbiology, The Alfred Hospital and Monash University, Melbourne, Australia
Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia
CSL Limited, Parkville, Australia
Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia
The Centre for Cancer Biology, SA Pathology, Adelaide, Australia
The Centre for Cancer Biology, SA Pathology, Adelaide, Australia;School of Medicine, University of Adelaide, Adelaide, Australia
The Centre for Cancer Biology, SA Pathology, Adelaide, Australia
Division of Haematology and Centre for Cancer Biology, SA Pathology, Adelaide, Australia
Children’s Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Sydney, Australia
Children’s Cancer Institute Australia, Lowy Cancer Research Centre, UNSW, Sydney, Australia
Vol. 100 No. 7 (2015): July, 2015 https://doi.org/10.3324/haematol.2014.113092